Welcome to Bios Health Group, your strategic partner in navigating the dynamic landscape of biotech and life science industries.
At Bios, we specialize in providing comprehensive guidance to early and growth-stage companies, empowering them to excel in investment, clinical development, and commercial strategy.
Our unique approach extends beyond traditional advisory roles. As both investors and venture partners, our fund invests in select biotech and life science ventures based on our investment criteria and current fund allocation status.
One of the things that sets us apart is our Bios Innovation Circle™ — a dynamic venture studio and strategic hub designed to catalyze the growth of startups and growing biotech and life science companies in a cost-effective and equity-sparing manner.
By leveraging this powerful network, we offer tailored solutions including an extensive network of investors and partners eager to support promising ventures from concept to commercialization.
At Bios Health Group, we’re committed to propelling biotech and life science companies toward their full potential.
Join us on a journey of innovation, partnership, and transformation.
Learn more watch our video
BioInvest
InnovateBio
CRO Select
LaunchMax
On Demand Executives
Through the Bios Innovation Circle™, we connect promising companies with the right resources and partnerships, fueling innovation in a cost-effective, equity-sparing way.
BioInvest
InnovateBio
CRO Select
LaunchMax
On Demand Executives
Our services
BioInvest
Discover the power of BioInvest, a groundbreaking platform by Bios Health Group for Investors and Startups. Seamlessly connect with promising biotech and healthcare startups, access cutting-edge research, and propel your investment portfolio to new heights. Access our Bios Innovation Circle™ to leverage solutions from partners in the forefront of innovation in healthcare and fuel the transformation of patient care. .
InnovateBio
Revolutionizing drug and device development through leveraging innovations and solutions such as Artificial intelligence, Digital Health, Precision Medicine, Real World Evidence Patient Centricity and others to accelerate timelines, reduce costs, enhance patient-centricity, and unlock the full potential of pharmaceutical and medical device advancements. Our initiative is dedicated to fostering a culture of innovation within the biopharmaceutical and life science industry. Leverage Accelerate by BHG™ our comprehensive and exclusive diagnostic tool empowers Biopharmaceutical companies to proactively recognize obstacles, prioritize tasks, offer effective solutions, plan and accelerate development..
CRO Selection & Management
Simplify and optimize your clinical trials with Bios Health Group's expert CRO selection and management services. Utilize our proprietary tool CRO Select by Bios Health Group ™ to guide the effective selection of the Right CRO for your clinical study. Our dedicated team ensures seamless coordination, efficient operations, and precise execution at every stage of your trial. Save time, reduce costs, and drive faster, more accurate results.
LaunchMax
Introducing Launch Max, the ultimate catalyst for life science ventures. Harness the expertise of Bios Health Group to accelerate your journey from concept to commercialization. Leverage our proprietary tool LaunchMax by Bios Health Group™ designed to identify key priorities, functions, obstacles, tasks, enabling companies to maximize their commercial success. Utilize our vast resources, strategic guidance, and industry insights to propel your venture forward. Fuel your success and make a lasting impact on global health.
On Demand Key Talent
Key talent remains a challenge in today’s dynamic market. Whether you are a small to mid-sized large bio-pharmaceutical or investment
Partner with us
The world’s response to COVID-19 has sped up innovation and out of the box thinking.
Testimonials
Bios Health Group’s strategic guidance and program management have been game-changers for our rare disease and CNS portfolio. Their ability to navigate the complexities of our therapeutic areas while providing clear, actionable insights allowed us to streamline our development efforts and make critical decisions with confidence. Their expertise in program management kept us on track and helped accelerate key milestones. Thanks to their unwavering support, we are in a stronger position to advance our pipeline and make a meaningful impact on patients’ lives.
Bios Health Group played an instrumental role in our successful $8M Series A raise. Their extensive investor network and deep understanding of what resonates with investors gave us a significant edge. From refining our pitch to introducing us to the right funding partners, their strategic guidance was invaluable. Thanks to their expertise, we are now well-positioned to advance our mission and take our development to the next level.
Bios Health Group exceeded our expectations in guiding us through critical decisions. Their deep expertise in indication prioritization and seamless support for our Orphan Drug Designation filing were pivotal in setting us up for both capital raising and advancing our clinical development. Their strategic insights and thorough approach have truly positioned us for success. Thank you for your exceptional work.